72 Followers on Owler

IBI S.A.

Read more
Gianni Pertici's photo - Co-Founder & CEO of IBI S.A.

Co-Founder & CEO

Gianni Pertici

CEO Approval Rating

88/100

Founded:

2008

Status:

PrivateIndependent Company

Est. Annual Revenue
$3M
Agree?
Est. Employees
12
Agree?

IBI S.A. TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

IBI S.A.'s company profile
Gianni Pertici's photo - Co-Founder & CEO of IBI S.A.

Gianni Pertici

Co-Founder & CEO

88/100
12
$0
$3M
View Profile
1
IBI S.A.'s Competitor - Kuros Biosciences AG logo
Joost De Bruijn's photo - CEO of Kuros Biosciences AG

Joost De Bruijn

CEO

90/100
28
$25.3M
$ < 1M
View Profile
2
IBI S.A.'s Competitor - NovImmune logo
Erik Trock Jansen's photo - CEO of NovImmune

Erik Trock Jansen

CEO

88/100
150
$248.6M
$40M
View Profile
3
IBI S.A.'s Competitor - Virometix logo
Anna Sumeray's photo - CEO of Virometix

Anna Sumeray

CEO

89/100
40
$14.3M
$10M
View Profile
4
IBI S.A.'s Competitor - iQone logo
Laurent Massuyeau's photo - Founder & CEO of iQone

Laurent Massuyeau

Founder & CEO

81/100
25
- -
$6.8M
View Profile
5
IBI S.A.'s Competitor - BiOrion logo
Herman Steen's photo - Co-Founder & CEO of BiOrion

Herman Steen

Co-Founder & CEO

72/100
711
- -
$5M
View Profile
6
IBI S.A.'s Competitor - Neotherix logo
Mike Raxworthy's photo - CEO of Neotherix

Mike Raxworthy

CEO

70/100
5
- -
$1.5M
View Profile
7
IBI S.A.'s Competitor - ADC Therapeutics logo
Chris Martin's photo - Co-Founder & CEO of ADC Therapeutics

Chris Martin

Co-Founder & CEO

89/100
208
$808.7M
$156.7M
View Profile
8
IBI S.A.'s Competitor - ADC Bio logo
Alan Raymond's photo - Chairman of ADC Bio

Alan Raymond

Chairman

87/100
38
$5.4M
$4M
View Profile

Missing a competitor? Contribute!

Kuros Biosciences AG is a top competitor of IBI S.A.. Kuros Biosciences AG was founded in 2000, and is headquartered in Schlieren, Zurich. Like IBI S.A., Kuros Biosciences AG also competes in the Biotechnology field. Kuros Biosciences AG generates $2.3M less revenue vs. IBI S.A..

NovImmune is seen as one of IBI S.A.'s top competitors. NovImmune is headquartered in Plan-les-Ouates, Geneva, and was founded in 1998. Like IBI S.A., NovImmune also operates in the Biotechnology field. NovImmune generates 1,333% the revenue of IBI S.A..

Virometix has been one of IBI S.A.'s top competitors. Virometix's headquarters is in Schlieren, Zurich, and was founded in 2009. Like IBI S.A., Virometix also works within the Biotechnology industry. Virometix generates 333% of IBI S.A.'s revenue.

IBI S.A. Acquisitions

No recent acquisitions found related to IBI S.A.

IBI S.A. Funding History

No recent funding data found related to IBI S.A.

IBI S.A. Investments

No recent investments found related to IBI S.A.

IBI S.A. Videos

Social Media

IBI S.A. Headquarters

Via Cantonale 67

Mezzovico-Vira, TicinoCH-6805

41-919-306-640

Driving Directions »

Trending Companies

IBI S.A. Summary

ABOUT

Overview

IBI is a biomedical company that focuses on developing medical devices for tissue engineering and regenerative medicine. IBI S.A. was founded in 2008. IBI S.A.'s headquarters is located in Mezzovico-Vira, Ticino, CH CH-6805. IBI S.A.'s Co-Founder & C...

CEO

IBI S.A.'s Co-Founder & CEO, Gianni Pertici, currently has an approval rating of 88%. IBI S.A.'s primary competitors are Kuros Biosciences AG, NovImmune & Virometix.

Website

ibi-sa.com

Frequently Asked Questions about IBI S.A.

  1. When was IBI S.A. founded?

    IBI S.A. was founded in 2008
  2. Who is IBI S.A.'s CEO?

    IBI S.A.'s CEO is Gianni Pertici
  3. How much revenue does IBI S.A. generate?

    IBI S.A. generates $3M in revenue
  4. How much funding does IBI S.A. have?

    IBI S.A. has historically raised $0 in funding
  1. Where is IBI S.A.'s headquarters?

    IBI S.A.'s headquarters is in Mezzovico-Vira Ticino, CH
  2. How many employees does IBI S.A. have?

    IBI S.A. has 12 employees
  3. What sector does IBI S.A. operate in?

    IBI S.A. is in Biotechnology
  4. Who are IBI S.A.'s competitors?

    IBI S.A.'s top competitors are Kuros Biosciences AG, NovImmune, Virometix